Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Respir Res ; 7: 129, 2006 Oct 17.
Artigo em Inglês | MEDLINE | ID: mdl-17044927

RESUMO

BACKGROUND: Previous genetic analysis has shown that a deletion in the complement component 5 gene-coding region renders mice more susceptible to allergen-induced airway hyperresponsiveness (AHR) due to reduced IL-12 production. We investigated the role of complement in a murine model of asthma-like pulmonary inflammation. METHODS: In order to evaluate the role of complement B10 mice either sufficient or deficient in C5 were studied. Both groups of mice immunized and challenged with a house dust extract (HDE) containing high levels of cockroach allergens. Airways hyper-reactivity was determined with whole-body plesthysmography. Bronchoalveolar lavage (BAL) was performed to determine pulmonary cellular recruitment and measure inflammatory mediators. Lung homogenates were assayed for mediators and plasma levels of IgE determined. Pulmonary histology was also evaluated. RESULTS: C5-deficient mice showed enhanced AHR to methylcholine challenge, 474% and 91% increase above baseline Penh in C5-deficient and C5-sufficient mice respectively, p < 0.001. IL-12 levels in the lung homogenate (LH) were only slightly reduced and BAL IL-12 was comparable in C5-sufficient and C5-deficient mice. However, C5-deficient mice had significantly higher cysteinyl-leukotriene levels in the BAL fluid, 1913 +/- 246 pg/ml in C5d and 756 +/- 232 pg/ml in C5-sufficient, p = 0.003. CONCLUSION: These data demonstrate that C5-deficient mice show enhanced AHR due to increased production of cysteinyl-leukotrienes.


Assuntos
Alérgenos/farmacologia , Broncoconstrição/efeitos dos fármacos , Complemento C5/genética , Complemento C5/metabolismo , Leucotrienos/metabolismo , Hipersensibilidade Respiratória/genética , Acetatos/farmacologia , Animais , Asma/metabolismo , Asma/patologia , Asma/prevenção & controle , Líquido da Lavagem Broncoalveolar/química , Colina/análogos & derivados , Colina/farmacologia , Baratas , Ciclopropanos , Modelos Animais de Doenças , Poeira , Predisposição Genética para Doença/genética , Imunoglobulina E/sangue , Interleucina-12/análise , Interleucina-12/metabolismo , Antagonistas de Leucotrienos/farmacologia , Camundongos , Camundongos Knockout , Quinolinas/farmacologia , Hipersensibilidade Respiratória/metabolismo , Hipersensibilidade Respiratória/patologia , Hipersensibilidade Respiratória/prevenção & controle , Sulfetos
2.
Cytokine ; 32(3-4): 178-85, 2005 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-16290175

RESUMO

The pathophysiology of asthma is influenced by exposure to allergens and endotoxin. Although the role of allergen-induced eosinophilia has been widely studied, neutrophil-mediated responses remain elusive. A role for neutrophils in the asthmatic responses is likely since human neutrophils have been shown to express IgE receptors, as well as receptors for many cytokines and chemokines implicated in the pathogenesis of asthma. In this study we investigated neutrophil involvement in a novel, house dust extract (HDE) induced model of asthma-like pulmonary inflammation. Mice were immunized and challenged with HDE containing high levels of cockroach allergens, 377 U/ml Bla g1 and 6249 ng/ml Bla g2. The biological activity of the murine chemokines KC and MIP-2 was inhibited with specific rabbit antisera. Differential counting of cells recovered from the bronchoalveolar lavage (BAL) fluid showed that neutralization of KC and MIP-2 significantly decreased pulmonary recruitment of neutrophils (reduced 86%) and lymphocytes (reduced 76%). Neutralization of these chemokines also exerted a systemic effect with a significant decrease in plasma IgE levels, 547 ng/ml+/-65 compared to 1314 ng/ml+/-247 for control sera treated animals. This study shows that CXC chemokines play an important role in allergy and asthma both at the level of pulmonary cell recruitment and systemic immune responses.


Assuntos
Alérgenos/imunologia , Asma/imunologia , Quimiocinas CXC/fisiologia , Imunoglobulina E/metabolismo , Pulmão/imunologia , Pulmão/patologia , Animais , Asma/patologia , Líquido da Lavagem Broncoalveolar , Quimiocina CXCL2 , Quimiocinas/antagonistas & inibidores , Quimiocinas/metabolismo , Modelos Animais de Doenças , Poeira/imunologia , Feminino , Imunoglobulina E/biossíntese , Inflamação/imunologia , Inflamação/metabolismo , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos BALB C
3.
Shock ; 21(1): 17-25, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14676679

RESUMO

In biomedical research using animal models, the phrase "humane endpoints" refers to predetermined criteria used to judge when the research animals should be humanely euthanized. The intended goal of humane endpoints is to minimize the distress or suffering of research animals; however, if applied incorrectly, this well-intended concept could lead to premature decisions and inaccurate data, resulting in a waste of animal life. A concensus on specific endpoints for shock and inflammation research is not available but several biochemical, physical and behavioral parameters have been suggested for other research models. In addition, the authors have found, in the studies presented here, that increasing body weight, decreased body temperature, and inability to ambulate are important parameters in a model of cecal ligation and puncture. However, it is clear that the applicability of these endpoints may change with the model of disease, intensity of insults, experimental treatments and other factors. Consequently, humane endpoints should be assigned cautiously and preferably after preliminary studies to prevent aberrant research results. In order to accomplish this, investigators must become aware of certain concepts including: when to implement endpoints, what endpoints to consider, and how to establish the endpoints for their studies. Equipped with the basic principles of humane endpoints, investigators can make informed decisions that meet current standards of animal care while still achieving the scientific goals of their research studies.


Assuntos
Projetos de Pesquisa , Sepse , Choque , Bem-Estar do Animal , Animais , Animais de Laboratório , Temperatura Corporal , Modelos Animais de Doenças , Eutanásia , Humanos , Camundongos , Ratos , Pesquisa , Fatores de Tempo
4.
Shock ; 18(6): 501-6, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12462556

RESUMO

A two-hit model of acid aspiration was used to examine the effect of keratinocyte growth factor (KGF) on chemokine levels and neutrophil recruitment into the lung. Mice were subjected to cecal ligation and puncture and then either KGF or saline, intratracheally (i.t.). Forty-eight hours later, the mice were given i.t. acid. After 8 h, neutrophil counts in bronchoalveolar lavage (BAL) fluid were significantly decreased in animals pretreated with KGF (23 +/- 4 x 10(3)/mouse) compared with saline (74 +/- 2 x 10(3)/mouse). In addition, the BAL fluid IL-6 levels were decreased in the KGF-treated group (88+/- 44 pg/mL) compared with the saline group (166 +/- 34 pg/mL). To examine the mechanism behind the KGF-induced reduction in neutrophil influx, the murine chemokines KC and macrophage inflammatory protein (MIP)-2alpha were measured. KC levels in plasma and BAL fluid were not significantly different between the treatment groups. Likewise, levels of MIP-2alpha in plasma were not affected by KGF treatment. However, 8 h after acid aspiration, MIP-2alpha concentrations were significantly lower in the KGF-treated group. The ratio of MIP-2alpha in BAL fluid versus plasma was lower in the KGF group (0.72 +/- 0.28) than in the saline group at 3 h (2.23 +/- 0.93) and also significantly lower in the KGF group (3.02 +/- 0.78) compared with the saline group (6.23 +/- 1.19) at 8 h. In this study, KGF pretreatment after acid aspiration was associated with reduced neutrophil recruitment into the lung and a decrease in MIP-2alpha gradients between BAL fluid and plasma.


Assuntos
Fatores de Crescimento de Fibroblastos/administração & dosagem , Fatores de Crescimento de Fibroblastos/farmacologia , Monocinas/metabolismo , Infiltração de Neutrófilos/efeitos dos fármacos , Neutrófilos/efeitos dos fármacos , Pneumonia Aspirativa/imunologia , Animais , Contagem de Células Sanguíneas , Líquido da Lavagem Broncoalveolar/citologia , Quimiocina CXCL2 , Quimiocinas/análise , Quimiocinas/sangue , Modelos Animais de Doenças , Feminino , Fator 7 de Crescimento de Fibroblastos , Pulmão/efeitos dos fármacos , Pulmão/imunologia , Pulmão/patologia , Camundongos , Camundongos Endogâmicos BALB C , Neutrófilos/imunologia , Pneumonia Aspirativa/sangue , Pneumonia Aspirativa/tratamento farmacológico , Pneumonia Aspirativa/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...